AMANDA WALLACE: Open Payments
NPI 1992408587 · APPLETON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Boston Scientific Corporation | 1 | $69 |
| Sage Therapeutics, LLC | 3 | $60 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
| Organon LLC | 2 | $31 |
| Exeltis, USA Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
Products named: LILETTA, ACCOLADE SR, ZURZUVAE, MYFEMBREE, NEXPLANON, SLYND, Qelbree, MONOFERRIC.
Industry payments across WI — which companies pay providers there.
